These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 684376)

  • 1. Human transfer factor in vitro: identification of L-serine and glycine as components with augmenting effect in lymphocyte transformation assay.
    Uotila A; Marnela KM; Hamblin A; Krohn K
    Scand J Immunol; 1978; 7(6):495-502. PubMed ID: 684376
    [No Abstract]   [Full Text] [Related]  

  • 2. Human transfer factor in vitro. II. Augmentation of the secretion of leucocyte migration inhibitory factor (LIF) by leucocyte dialysate and by its components L-serine and glycine.
    Ashorn RG; Räsänen L; Marnela KM; Krohn KJ
    Clin Exp Immunol; 1979 Jul; 37(1):50-7. PubMed ID: 385187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionation studies on human leucocyte dialyzates. Demonstration of three components with transfer factor activity.
    Krohn K; Gröhn P; Horsmanheimo M; Virolainen M
    Med Biol; 1976 Dec; 54(5):334-40. PubMed ID: 994567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography.
    Vandenbark AA; Burger DR; Dreyer DL; Daves GD; Vetto RM
    J Immunol; 1977 Feb; 118(2):636-41. PubMed ID: 839073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of 3H-thymidine incorporation by human lymphocytes in the presence of antigen and fractions of dialyzable transfer factor: a nonspecific phenomenon.
    Littman BH; Hirschman EM; David JR
    Cell Immunol; 1977 Jan; 28(1):158-66. PubMed ID: 64313
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical analysis of dialyzable leukocyte extracts.
    Gottlieb AA; Saito K; Sutcliffe S; Foster LA; Tamaki N; Maziarz G; Sutherland C; Brennessel B
    J Reticuloendothel Soc; 1977 Jun; 21(6):403-16. PubMed ID: 886545
    [No Abstract]   [Full Text] [Related]  

  • 7. Human transfer factor: fractionation and biologic activity.
    Burger DR; Vandenbark AA; Daves D; Anderson WA; Vetto RM; Finke P
    J Immunol; 1976 Sep; 117(3):789-96. PubMed ID: 134121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialyzable transfer factor in experimental Chagas' disease: in vitro studies.
    Machado RZ; Laure CJ; De Lucca FL
    Trop Med Parasitol; 1986 Dec; 37(4):399-402. PubMed ID: 3105040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Tx, an active subfraction of human dialyzable transfer factor. I. Identification of the major component in TFg, a precursor of Tx, as hypoxanthine.
    Wilson GB; Welch TM; Knapp DR; Horsmanheimo A; Fudenberg HH
    Clin Immunol Immunopathol; 1977 Nov; 8(3):551-68. PubMed ID: 912950
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of transfer factor on lymphocyte transformation. Comparison of augmentation by dialysates of leucocytes and lymphoid and non-lymphoid organs.
    Uotila A; Hamblin A; Dumonde DC; Krohn KJ
    Int Arch Allergy Appl Immunol; 1978; 57(3):210-20. PubMed ID: 659013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of tuberculin-induced lymphocyte transformation by precultivated macrophages from patients with sarcoidosis.
    Horsmanheimo M; Virolainen M
    Scand J Immunol; 1974; 3(1):21-7. PubMed ID: 4857242
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfer factor.
    Baram P
    IMJ Ill Med J; 1976 May; 149(5):448-52, 484. PubMed ID: 6377
    [No Abstract]   [Full Text] [Related]  

  • 13. Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor.
    Burger DR; Vandenbark AA; Daves D; Anderson WA; Vetto RM; Finke P
    J Immunol; 1976 Sep; 117(3):797-801. PubMed ID: 134122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of "dialyzable transfer factor" in vitro: structural and chemical characterization of the activity specific for tuberculin.
    Wilson GB; Fudenberg HH; Paddock GV
    Ann N Y Acad Sci; 1979; 332():579-90. PubMed ID: 294834
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of human leukocyte interferon on the response of lymphocytes to mitogenic stimuli in vitro.
    Blomgren H; Strander H; Cantell K
    Scand J Immunol; 1974; 3(6):697-705. PubMed ID: 4281930
    [No Abstract]   [Full Text] [Related]  

  • 16. Dialyzable leukocyte extract: partial purification of low-molecular-weight factors suppressing and enhancing lymphocyte transformation.
    Rosso di San Secondo VE; Lugaro G; Sirchia G
    J Exp Pathol; 1987; 3(4):425-7. PubMed ID: 3454803
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor.
    O'Dorisio MS; Neidhart JA; Daniel FB; Balcerzak SP; LoBuglio AF
    Cell Immunol; 1976 May; 23(2):191-202. PubMed ID: 1277303
    [No Abstract]   [Full Text] [Related]  

  • 18. Human tonsil lymphocytes in the transfer of cell-mediated immunity.
    Giannitsis DJ; Mootz W; Larovici A; Taubert W; Fuchs R
    Cytobios; 1979; 24(95 96):181-4. PubMed ID: 527374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of beta2-microglobulin from transfer factor in dialyzable leukocyte extracts.
    Nékám K; Kelemen GS; Varró R; Fekete B; Láng I; Kalmár L; Gergely P; Petrányi G
    Allerg Immunol (Leipz); 1978; 24(4):254-8. PubMed ID: 84525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the chemical nature of dialysable transfer factor. Comparison of human leukocyte dialysate and dialysates derived from human serum and from mammalian lymphoid and non-lymphoid organs.
    Uotila A
    Immunobiology; 1980 Jan; 156(4-5):353-63. PubMed ID: 7372348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.